Resveratrol suppresses agonist-induced monocyte adhesion to cultured human endothelial cells

Thrombosis Research

Volumn 106, Issue 4-5, 2002, Pages 243-248

  Pendurthi, Usha R ^a   Rao, L Vijaya Mohan ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Atherosclerosis; Cell adhesion; E selectin; Endothelial cells; Monocytes; Resveratrol

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MESSENGER RNA; RESVERATROL; CYTOKINE; STILBENE DERIVATIVE;

ARTICLE; CELL ADHESION; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; CYTOLOGY; DRUG ANTAGONISM; DRUG INTERACTION; GENETICS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL ADHESION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; DRUG INTERACTIONS; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; MONOCYTES; RNA, MESSENGER; STILBENES; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0037092636     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00141-X     Document Type: Article

References (34)

1. Suh I., Shaten B.J., Cutler J.A., Kuller L.H. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The multiple risk factor intervention trial research group. Ann. Intern. Med. 116:1992;881-887.
2. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am. J. Clin. Nutr. 55:1992;1012-1017.
3. Renaud S., De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1993;1523-1526.
4. Soleas G.J., Diamandis E.P., Goldberg D.M. Wine as biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 11:1997;287-313.
5. Seimann E.H., Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 43:1992;49-52.
6. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet. 341:1993;1103-1104.
7. Bertelli A.A.E., Giovannini L., Giannessi D., Migliori M., Bernini W., Fregoni M.et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React. 17:1995;1-3.
8. Pace-Asciak C.R., Hahn S., Diamandis E.P., Soleas G., Goldberg D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta. 235:1995;207-219.
9. Hsieh T.-Z., Juan G., Darzynkiewicz Z., Wu J.M. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21, and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59:1999;2596-2601.
10. Chen C.K., Pace-Asciak C.R. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen. Pharmacol. 27:1996;363-366.
11. Pendurthi U.R., Williams J.T., Rao L.V.M. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler. Thromb. Vasc. Biol. 19:1999;419-426.
12. Pendurthi U.R., Meng F., Mackman N., Rao L.V.M. Mechanism of resveratrol-mediated suppression of tissue factor gene expression. Thromb. Haemost. 87:2002;155-162.
13. Ardissino D., Merlini P.A., Arlens R., Coppola R., Bramucci E., Lucreziotti S.et al. Tissue factor in human coronary atherosclerotic plaques. Clin. Chim. Acta. 291:2000;235-240.
14. Ardissino D., Merlini P.A., Bauer K.A., Bramucci E., Ferrario M., Coppola R.et al. Thrombogenic potential of human coronary atherosclerotic plaques. Blood. 98:2001;2726-2729.
15. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:1995;791-804.
16. Chia M.C. The role of adhesion molecules in atherosclerosis. CRC Crit. Rev. Clin. Lab. Sci. 35:1998;573-602.
17. Collins T. Biology of disease: endothelial nuclear factor-kappa B and the initiation of atherosclerotic lesion. Lab. Invest. 68:1993;499-508.
18. Tsai S.H., Lin-Shiau S.-Y., Lin J.K. Suppression of nitrite oxide synthase and the down-regulation of the activation of NF-kB in macrophages by resveratrol. Br. J. Pharmacol. 126:1999;673-680.
19. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kB, activator protein-1 and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:2000;6509-6519.
20. Homes-McNary M., Baldwin A.S. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkB kinase. Cancer Res. 60:2000;3477-3483.
21. Krakauer T. A sensitive ELISA for measuring the adhesion of leukocytic cells to human endothelial cells. J. Immunol. Methods. 177:1994;207-213.
22. Devaraj S., Li D., Jialal I. The effects of alpha tocopherol supplementation on monocyte function. J. Clin. Invest. 98:1996;756-763.
23. Faruqi R., de la Motte C., Dicorleto P.E. α-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94:1994;592-600.
24. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? and gone? Clin. Biochem. 30:1997;91-113.
25. Frémont L. Biological effects of resveratrol. Life Sci. 66:2000;663-673.
26. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 337:1999;1360-1369.
27. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
28. Ferrero M.E., Bertelli A.A.E., Fulgenzi A., Pellegatta F., Corsi M.M., Bonfrate M.et al. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am. J. Clin. Nutr. 68:1998;1208-1214.
29. Goldberg D.M., Yan J., Ng E., Diamandis E.P., Karumanchiri A., Soleas G.et al. A global survey of trans-resveratrol concentrations in commercial wines. Am. J. Enol. Vitic. 46:1995;159-165.
30. Bertelli A.A.E., Giovannini L., Stradi R., Urien S., Tillement J.-P., Bertelli A. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp. Clin. Res. 24:1998;51-55.
31. Pace-Asciak C.R., Rounova O., Hahn S.E., Diamandis E.P., Goldberg D.M. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta. 246:1996;163-182.
32. Seigneur M., Bonnet J., Dorian B. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. J. Appl. Cardiol. 5:1990;215-222.
33. Whitehead T.P., Robinson D., Allaway S., Syms J., Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin. Chem. 41:1995;32-35.
34. Booyse F.M., Parks D.A. Moderate wine and alcohol consumption: beneficial effects on cardiovascular disease. Thromb. Haemost. 86:2001;517-528.